Resveratrol induces cell death in colorectal cancer cells by a novel pathway involving lysosomal cathepsin D
Open accessAbstract
In human colorectal cancer cells, the polyphenol resveratrol (RV) activated the caspase-dependent intrinsic pathway of apoptosis. This effect was not mediated via estrogen receptors. Pepstatin A, an inhibitor of lysosomal cathepsin D (CD), not (2S,3S)-trans-epoxysuccinyl-L-leucylamido-3-methylbutane ethyl ester, an inhibitor of cathepsins B and L, prevented RV cytotoxicity. Similar protection was attained by small interference RNA-mediated knockdown of CD protein expression. RV promoted the accumulation of mature CD, induced lysosome leakage and increased cytosolic immunoreactivity of CD. Inhibition of CD or its post-transcriptional down-regulation precluded Bax oligomerization, permeabilization of mitochondrial membrane, cytosolic translocation of cytochrome c, caspase 3 activation and terminal deoxinucleotidyl transferase-mediated dUTP-biotin nick end labeling positivity occurring in RV-treated cells. The present study identifies the lysosome as a novel target of RV activity and demonstrates a hierarchy of the proteolytic pathways involved in its cytotoxic mechanism in which the lysosomal CD acts upstream of the cytosolic caspase activation. Our data indicate that metabolic, pharmacologic or genetic conditions affecting CD expression and/or activity could reflect on the sensitivity of cancer cells to RV.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
CTSL plays a key role in regulating autophagic adaptation vs. RCD in cells responding to resveratrol.
“Moreover, CTSL appears to play a key role in the regulation of autophagic adaptation vs. RCD in cells responding to the LMP inducer resveratrol [783, 784].”
From Molecular mechanisms of cell death: recommendations of the nomenclature committee on cell death 2018. (2018) · cites this paper as [784]
Cites
Cancer chemopreventive activity of resveratrol, a natural product derived from grapes
Jang, M., Cai, L., Udeani, G. O., Slowing, K. V., Thomas, C. F., Beecher, C. W. W., Fong, H. H. S., Farnsworth, N. R., Kinghorn, A. D., Mehta, R. G., et al. (1997) · Science · doi:10.1126/science.275.5297.218 · Cited by 4,935 · see citing works
Danial, N. N., & Korsmeyer, S. J. (2004) · Cell · doi:10.1016/s0092-8674(04)00046-7 · Cited by 4,651 · see citing works
Proapoptotic BAX and BAK: A Requisite Gateway to Mitochondrial Dysfunction and Death
Wei, M. C., Zong, W.-X., Cheng, E. H.-Y., Lindsten, T., Panoutsakopoulou, V., Ross, A. J., Roth, K. A., MacGregor, G. R., Thompson, C. B., & Korsmeyer, S. J. (2001) · Science · doi:10.1126/science.1059108 · Cited by 3,988 · see citing works
Therapeutic potential of resveratrol: the in vivo evidence
Baur, J. A., & Sinclair, D. A. (2006) · Nature Reviews Drug Discovery · doi:10.1038/nrd2060 · Cited by 3,958 · see citing works
Role of resveratrol in prevention and therapy of cancer: preclinical and clinical studies.
Aggarwal, B. B., Bhardwaj, A., Aggarwal, R. S., Seeram, N. P., Shishodia, S., & Takada, Y. (2004) · PubMed · Cited by 1,383 · see citing works
Cell Death Independent of Caspases: A Review
Bröker, L. E., Kruyt, F. A. E., & Giaccone, G. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-2223 · Cited by 899 · see citing works
Role of <i>BAX</i> in the Apoptotic Response to Anticancer Agents
Zhang, L., Yu, J., Park, B. H., Kinzler, K. W., & Vogelstein, B. (2000) · Science · doi:10.1126/science.290.5493.989 · Cited by 863 · see citing works
Guicciardi, M. E., Leist, M., & Gores, G. J. (2004) · Oncogene · doi:10.1038/sj.onc.1207512 · Cited by 716 · see citing works
Guicciardi, M. E., Deussing, J. M., Miyoshi, H., Bronk, S. F., Svingen, P. A., Peters, C., Kaufmann, S. H., & Gores, G. J. (2000) · Journal of Clinical Investigation · doi:10.1172/jci9914 · Cited by 710 · see citing works
Cancer Chemopreventive Activity of Resveratrol
Bhat, K. P. L., & Pezzuto, J. (2002) · Drugs under experimental and clinical research · doi:10.1111/j.1749-6632.2002.tb02918.x · Cited by 633 · see citing works
Foghsgaard, L., Wissing, D., Mauch, D., Lademann, U. A., Bastholm, L., Boes, M. L., Elling, F., Leist, M., & Jäättelä, M. (2001) · The Journal of Cell Biology · doi:10.1083/jcb.153.5.999 · Cited by 629 · see citing works
Resveratrol Acts as a Mixed Agonist/Antagonist for Estrogen Receptors α and β*
Bowers, J. L., Tyulmenkov, V. V., Jernigan, S. C., & Klinge, C. M. (2000) · Endocrinology · doi:10.1210/endo.141.10.7721 · Cited by 527 · see citing works
Anticancer therapy targeting the apoptotic pathway
Hu, W., & Kavanagh, J. J. (2003) · The Lancet Oncology · doi:10.1016/s1470-2045(03)01277-4 · Cited by 511 · see citing works
Deiss, L. P., Galinka, H., Berissi, H., Cohen, O., & Kimchi, A. (1996) · The EMBO Journal · doi:10.1002/j.1460-2075.1996.tb00760.x · Cited by 465 · see citing works
Antiestrogen ICI 164,384 reduces cellular estrogen receptor content by increasing its turnover.
Dauvois, S., Danielian, P. S., White, R., & Parker, M. G. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.9.4037 · Cited by 462 · see citing works
Joe, A. K., Liu, H., Suzui, M., Vural, M. E., Xiao, D., & Weinstein, I. B. (2002) · PubMed · Cited by 455 · see citing works
Bidère, N., Lorenzo, H. K., Carmona, S., Laforge, M., Harper, F., Dumont, C., & Senik, A. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m301911200 · Cited by 435 · see citing works
Banerjee, S., Bueso-Ramos, C., & Aggarwal, B. B. (2002) · PubMed · Cited by 423 · see citing works
Resveratrol-induced Autophagocytosis in Ovarian Cancer Cells
Opipari, A. W., Tan, L., Boitano, A. E., Sorenson, D. R., Aurora, A., & Liu, J. R. (2004) · Cancer Research · doi:10.1158/0008-5472.can-03-2404 · Cited by 377 · see citing works
Expression of estrogen receptor (ER) subtypes and ERbeta isoforms in colon cancer.
Campbell‐Thompson, M., Lynch, I. J., & Bhardwaj, B. (2001) · PubMed · Cited by 365 · see citing works
Hsieh, T., & WU, J. M. (1999) · Experimental Cell Research · doi:10.1006/excr.1999.4471 · Cited by 361 · see citing works
Schneider, Y., Vincent, F., Duranton, B., Badolo, L., Gossé, F., Bergmann, C., Seiler, N., & Raul, F. (2000) · Cancer Letters · doi:10.1016/s0304-3835(00)00511-5 · Cited by 341 · see citing works
Resveratrol suppresses cell transformation and induces apoptosis through a p53-dependent pathway
Huang, C. (1999) · Carcinogenesis · doi:10.1093/carcin/20.2.237 · Cited by 338 · see citing works
Cathepsin D links TNF-induced acid sphingomyelinase to Bid-mediated caspase-9 and -3 activation
Heinrich, M., Neumeyer, J., Jakob, M., Hallas, C., Tchikov, V., Winoto‐Morbach, S., Wickel, M., Schneider‐Brachert, W., Trauzold, A., Hethke, A., et al. (2004) · Cell Death and Differentiation · doi:10.1038/sj.cdd.4401382 · Cited by 333 · see citing works
Cloning and sequence analysis of cDNA for human cathepsin D.
Faust, P. L., Kornfeld, S. A., & Chirgwin, J. M. (1985) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.82.15.4910 · Cited by 322 · see citing works
Tessitore, L., Davit, A., Sarotto, I., & Caderni, G. (2000) · Carcinogenesis · doi:10.1093/carcin/21.5.619 · Cited by 281 · see citing works
Sale, S., Verschoyle, R. D., Boocock, D. J., Jones, D. J. L., Wilsher, N. E., Ruparelia, K. C., Potter, G. A., Farmer, P. B., Steward, W. P., & Gescher, A. J. (2004) · British Journal of Cancer · doi:10.1038/sj.bjc.6601568 · Cited by 260 · see citing works
Resveratrol, a Natural Product Present in Wine, Decreases Tumour Growth in a Rat Tumour Model
Carbó, N., Costelli, P., Baccino, F. M., López-Soriano, F. J., & Argilés, J. M. A. (1999) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1998.9916 · Cited by 255 · see citing works
Wolter, F., Akoglu, B., Clausnitzer, A., & Stein, J. M. (2001) · Journal of Nutrition · doi:10.1093/jn/131.8.2197 · Cited by 235 · see citing works
Pozo‐Guisado, E., Alvarez, A. M., Mulero‐Navarro, S., Santiago‐Josefat, B., & Fernández‐Salguero, P. M. (2002) · Biochemical Pharmacology · doi:10.1016/s0006-2952(02)01296-0 · Cited by 233 · see citing works
Resveratrol Suppresses the Angiogenesis and Tumor Growth of Gliomas in Rats
Tseng, S.-H., Lin, S.-M., Chen, J.-C., Su, Y., Huang, H., Chen, C.-K., Lin, P.-Y., & Chen, Y. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-03-0105 · Cited by 217 · see citing works
Bröker, L. E., Huisman, C., Span, S. W., Rodríguez, J. A., Kruyt, F. A. E., & Giaccone, G. (2004) · Cancer Research · doi:10.1158/0008-5472.can-03-3060 · Cited by 206 · see citing works
Tinhofer, I., Bernhard, D., Senfter, M., Anether, G., Loeffler, M. W., Kroemer, G., Kofler, R., Csordás, A., & Greil, R. (2001) · The FASEB Journal · doi:10.1096/fj.00-0675fje · Cited by 183 · see citing works
Cao, Z., Fang, J. S., Xia, C., Shi, X., & Jiang, B. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-03-0588 · Cited by 173 · see citing works
Li, Z. (2002) · Carcinogenesis · doi:10.1093/carcin/23.9.1531 · Cited by 169 · see citing works
Park, J.-W. (2001) · Carcinogenesis · doi:10.1093/carcin/22.10.1633 · Cited by 130 · see citing works
Functional Estrogen Receptor β in Colon Cancer Cells
Fiorelli, G., Picariello, L., Martineti, V., et al. (1999) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1999.1062 · Cited by 125 · see citing works
Bhat, K., & Pezzuto, J. M. (2001) · PubMed · Cited by 119 · see citing works
Levenson, A. S., Gehm, B. D., Pearce, S. T., Horiguchi, J., Simons, L. A., Ward, J. E., Jameson, J. L., & Jordan, V. C. (2003) · International Journal of Cancer · doi:10.1002/ijc.10992 · Cited by 119 · see citing works
Hsieh, T. C., Burfeind, P., Laud, K., et al. (1999) · International Journal of Oncology · doi:10.3892/ijo.15.2.245 · Cited by 114 · see citing works
Oestrogen-induced apoptosis in colonocytes expressing oestrogen receptor beta
Qiu, Y., Waters, C., Lewis, A., Langman, M. J. S., & Eggo, M. (2002) · Journal of Endocrinology · doi:10.1677/joe.0.1740369 · Cited by 111 · see citing works
Lysosomal Cysteine Proteases: Structural Features and their Role in Apoptosis
Stoka, V., Turk, B., & Türk, V. (2005) · IUBMB Life · doi:10.1080/15216540500154920 · Cited by 106 · see citing works
Emert‐Sedlak, L. A., Shangary, S. K., Rabinovitz, A., Miranda, M. B., Delach, S. M., & Johnson, D. E. (2005) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-04-0301 · Cited by 93 · see citing works
Role of Bax in resveratrol-induced apoptosis of colorectal carcinoma cells
Mahyar-Roemer, M., Köhler, H., & Roemer, K. (2002) · BMC Cancer · doi:10.1186/1471-2407-2-27 · Cited by 90 · see citing works
Gao, M., Ossowski, L., & Ferrari, A. C. (1999) · Journal of Cellular Physiology · doi:10.1002/(sici)1097-4652(199906)179:3 · Cited by 86 · see citing works
Chen, A.-C., & Donovan, S. M. (2004) · Journal of Nutrition · doi:10.1093/jn/134.6.1303 · Cited by 72 · see citing works
Destination ‘Lysosome’: a target organelle for tumour cell killing?
Castino, R., Démoz, M., & Isidoro, C. (2003) · Journal of Molecular Recognition · doi:10.1002/jmr.643 · Cited by 71 · see citing works
Self-citationDémoz, M., Castino, R., Cesaro, P., et al. (2002) · Biological Chemistry · doi:10.1515/bc.2002.137 · Cited by 39 · see citing works
Self-citationResveratrol Enhances the Differentiation Induced by Butyrate in Caco-2 Colon Cancer Cells
Wolter, F., & Stein, J. M. (2002) · Journal of Nutrition · doi:10.1093/jn/132.7.2082 · Cited by 38 · see citing works
Vyas, S., Asmerom, Y., & León, D. D. (2006) · Growth Factors · doi:10.1080/08977190500366068 · Cited by 15 · see citing works
Démoz, M., Castino, R., Follo, C., Hasilík, A., Sloane, B. F., & Isidoro, C. (2005) · Protein Expression and Purification · doi:10.1016/j.pep.2005.07.024 · Cited by 13 · see citing works
Self-citation
Flagged first, then by citations
Cited by
Sorted by citations
Galluzzi, L., Vitale, I., Aaronson, S. A., Abrams, J. M., Adam, D., Agostinis, P., Alnemri, E. S., Altucci, L., Amelio, I., Andrews, D. W., et al. (2018) · Cell Death & Differentiation · doi:10.1038/s41418-017-0012-4 · Cited by 6,680 · see citing works
Lysosomal cell death mechanisms in aging
Gómez-Sintes, R., Ledesma, M. D., & Boya, P. (2016) · Ageing Research Reviews · doi:10.1016/j.arr.2016.02.009 · Cited by 216 · see citing works
- Authors
- Trincheri, N. F., Nicotra, G., Follo, C., Castino, R., & Isidoro, C.
- Affiliations
- Università degli Studi del Piemonte Orientale “Amedeo Avogadro” (IT)
- Corresponding author
- Isidoro, C.
- ORCID
- Venue
- Carcinogenesis
- Publisher
- Oxford University Press (OUP)
- Published
- 2006-11-27
- Volume
- 28
- Issue
- 5
- Pages
- 922-931
- ISSN
- 0143-3334 (ISSN-L)
- 1460-2180
- OpenAlex
- W2116178196
- Cited by
- 122
- References
- 51
- Citations by year
- 2026: 1 · 2025: 1 · 2024: 2 · 2023: 3 · 2022: 7 · 2021: 5 · 2020: 6 · 2019: 7 · 2018: 8 · 2017: 7 · 2016: 8 · 2015: 7 · 2014: 5 · 2013: 12 · 2012: 10
- FWCI
- 2.73
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by
- Locations
- Carcinogenesis (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Geriatrics and Gerontology › Sirtuins and Resveratrol in Medicine
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Cell death mechanisms and regulation
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Protease and Inhibitor Mechanisms
- Keywords
- resveratrol, colorectal cancer, cathepsin D, lysosomal cathepsins, apoptosis, caspase-3 activation, Bax oligomerization, mitochondrial membrane permeabilization, cytochrome c release, lysosomal proteolysis, pepstatin A
- MeSH terms
- Resveratrol, Cathepsin D, Cathepsins, Cell Line, Cysteine Endopeptidases, Cytosol, Dose-Response Relationship, Drug, Humans, Lysosomes, Stilbenes, Time Factors, Colorectal Neoplasms, Cell Death, HT29 Cells, Cytochromes c, Cathepsin L, Caspase Inhibitors
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review